B-type natriuretic peptide in heart transplantation an important marker of allograft performance

Heart Failure Reviews

Volumn 8, Issue 4, 2003, Pages 359-363

  Park, Myung H ^a   Uber, Patricia A ^a   Scott, Robert L ^a   Mehra, Mandeep R ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

B type natriuretic peptide (BNP); Cardiac rejection; Diastolic dysfunction; Heart transplantation; Hemodynamics; Right ventricular dysfunction; Tricuspid regurgitation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; NEUROHORMONE; PREDNISONE; STEROID;

ADAPTATION; ASSAY; CLINICAL TRIAL; CORRELATION FUNCTION; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; ENDOCARDIAL BIOPSY; GRAFT REJECTION; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE WALL; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE PRESSURE; HUMAN; HYPERTENSION; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTOLIC BLOOD PRESSURE;

BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; TRANSPLANTATION TOLERANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0346895172     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026199400166     Document Type: Review

References (29)

1. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart: Production in the ventricle. Hypertension 1991;17:1152-1156.
2. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H, Saito Y, Suga S, Jougasaki M, Imura H. Natri-uretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circulation Research 1991;69:491-500.
3. Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure [Letter]. N Engl J Med 1990;323;757-758.
4. Yoshimura M, Yasue H, Okamura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-469.
5. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1991;92:29-34.
6. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DRJ, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clinical Science 1992;83:437-444.
7. Ationu A, Burch M, Singer D, Littleton P, Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovascular Research 1993;27:188-191.
8. Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children - A three year follow up. Cardiovascular Research 1993;27:2135-2139.
9. El Gamel A, Yonan NA, Keevil B, Warbuton R, Kakadellis J, Woodcock A, Campbell CS, Rahman AN, Deiraniya AK. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg 1997;63:1095-1100.
10. Geny B, Follenius M, Epailly E, Charpentier A, Brandenberger G, Eisenmann B, Haberey P, Piquard F. Transient reduction without normalization of brain natriuretic peptide early after heart transplantation. J Thorac Cardiovasc Surg 1998;115:473-475.
11. Buckley MG, Yacoub MH, Singer DRJ. Investigation of the plasma concentrations and circulating forms of BNP and ANP in orthotopic cardiac transplant recipients. J of Human Hypertension 1998;12:825-826.
12. Masters RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, De Bold AJ. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287-291.
13. Murdoch DR, Byrne J, Morten JJ. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice. Heart 1997;78:594-597.
14. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.
15. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation 2002;106:416-422.
16. Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR. Usefulness of b-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 2002;90:1326-1329.
17. Dao Q, Krishnaswany P, Kazanegra R, et al. Utility of b-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-385.
18. Kazanegra R, Cheng V, Gaccia A, Krishnaswamy P, Gasdetto N, Clopton P, Maisel AS. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressure in patients treated for decompensated heart failure: A pilot study. J Card Fail 2001;7:21-29.
19. Cheung BMY. Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension. Clin Exp Phamacol and Physiol 1997;24:966-968.
20. Lubien E, DeMaria A, Krishnaswamy P, Cloptin P, Koon J, Kazanegra R, Gardetto N, Warner E, Maisel AS. Utility of b-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity reading. Circulation 2002;105:595-601.
21. Bhatia SJ, Kirshenbaum JM, Shemin RJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthopic cardiac transplantation. Circulation 1987;76:819-826.
22. Chan MCY, Giannetti N, Kornbluth M, Valentine HA, Hunt SA. Severe tricuspid regurgitation after heart transplantation. J Heart Lung Transplant 2001;20:709-717.
23. Mehra MR, Uber PA, Uber WE, Park MH, Scott RL. Anything but a biopsy: Noninvasive monitoring for cardiac allograft rejection. Current Opinion in Cardiology 2002;17:131-136.
24. Master RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, De Bold AJ. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287-291.
25. Park MH, Scott RL, Uber PA, Mehra MR. Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart Lung Transplant 2002;21:613-614.
26. Uber PA, Mehra MR, Harris B, Scott RL, Park MH. Steroid weaning in heart transplantation is associated with decreased b-type natriuretic peptide: Surrogate evidence of cardiac adaptation. Transplant Proc 2002;34:1843-1844.
27. Park MH, Uber PA, Nasca PF, Scott RL, Mehra MR. Temporal patterns in b-type natriuretic peptides predict cardiac hospitalizations in heart transplantation. J Heart Lung Transplant 2003;22:S157.
28. Mehra MR, Uber PA, Park MH, Scott RL. B-Type natriuretic peptide and peak aerobic capacity: Insights into allograft determinants of exercise limitations following heart transplantation. J Heart & Lung Transplant 2002;21(1):90/98.
29. Park MH, Uber PA, Scott RL, Bourgeois LE, Mehra MR. Renin-angiotensin-aldosterone-system directed anti-hypertensive therapy achieves lower B-type natriuretic peptide levels compared with calcium channel blockade in heart transplantation. J Heart & Lung Transplant 2002;21(1):120/180.